BOOKBINDER ET AL: "A recombinant human enzyme for enhanced interstitial transport of therapeutics", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 114, no. 2, 28 August 2006 (2006-08-28), pages 230-241, XP005625403, ISSN: 0168-3659, DOI: 10.1016/J.JCONREL.2006.05.027 (B1)

EP-A2- 0 278 422 (B1)

LEESCH V W ET AL: "30-Day Pharmacokinetic Evaluation of IV versus Subcutaneous Administration of Immunoglobulin with and without Recombinant Human Hyaluronidase in Dogs", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, MOSBY, INC, US, vol. 123, no. 2, Suppl. S, 1 February 2009 (2009-02-01), page S10, XP002541722, ISSN: 0091-6749, DOI: 10.1016/J.JACI.2008.12.051 (B1)

MELAMED I R ET AL: "Recombinant human hyaluronidase facilitates dispersion of subcutaneously administered Gammagard liquid and enables administration of a full monthly bose in a single site to patients with immunodeficiency diseases", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, MOSBY, INC, US, vol. 121, no. 2, Suppl. 1, 1 February 2008 (2008-02-01), page S83, XP002541721, ISSN: 0091-6749, DOI: 10.1016/J.JACI.2007.12.332 (B1)

WO-A1-2009/117085 (B1)

SKODA-SMITH SUZANNE ET AL: "Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease", THERAPEUTICS AND CLINICAL RISK MANAGEMENT, vol. 6, 23 August 2011 (2011-08-23), pages 1-10, XP002657372, ISSN: 1178-203X (B1)

US-A1- 2006 104 968 (B1)

US-A1- 2008 171 014 (B1)

MISBAH S ET AL: "Subcutaneous immunoglobulin: opportunities and outlook", CLINICAL AND EXPERIMENTAL IMMUNOLOGY, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 158, no. Suppl. 1, 1 January 2009 (2009-01-01), pages 51-59, XP002585722, ISSN: 0009-9104, DOI: 10.1111/J.1365-2249.2009.04027.X [retrieved on 2009-10-30] (B1)